sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

Category : Pharmaceuticals and Healthcare QY Research Pages :111
Published Date : 2020-09-14

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Hereditary Angioedema Treatment Market with our analysts monitoring the situation across the globe.
Hereditary Angioedema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Hereditary Angioedema Treatment market is segmented into C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Selective Bradykinin B2 Receptor Antagonists (Firazyr) Kallikrein Inhibitors (Kalbitor, Takhzyro) Others (Conventional Drugs, Pipeline Drugs) Segment by Application, the Hereditary Angioedema Treatment market is segmented into Hospital Pharmacies Retail Pharmacies Others (online pharmacies, mail pharmacies) Regional and Country-level Analysis The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries). The key regions covered in the Hereditary Angioedema Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Hereditary Angioedema Treatment Market Share Analysis Hereditary Angioedema Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema Treatment business, the date to enter into the Hereditary Angioedema Treatment market, Hereditary Angioedema Treatment product introduction, recent developments, etc. The major vendors covered: CSL Pharming Group Shire plc (Takeda Pharmaceutical Company Limited) Ionis Pharmaceuticals Attune Pharmaceuticals BioCryst Pharmaceuticals KalVista Pharmaceuticals ...
1 Study Coverage 1.1 Hereditary Angioedema Treatment Product Introduction 1.2 Market Segments 1.3 Key Hereditary Angioedema Treatment Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Type 1.4.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products) 1.4.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr) 1.4.4 Kallikrein Inhibitors (Kalbitor, Takhzyro) 1.4.5 Others (Conventional Drugs, Pipeline Drugs) 1.5 Market by Application 1.5.1 Global Hereditary Angioedema Treatment Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Others (online pharmacies, mail pharmacies) 1.6 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry 1.6.1.1 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts 2.1.1 Global Hereditary Angioedema Treatment Revenue 2015-2026 2.1.2 Global Hereditary Angioedema Treatment Sales 2015-2026 2.2 Hereditary Angioedema Treatment Market Size by Region: 2020 Versus 2026 2.2.1 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Hereditary Angioedema Treatment Competitor Landscape by Players 3.1 Hereditary Angioedema Treatment Sales by Manufacturers 3.1.1 Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020) 3.1.2 Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2015-2020) 3.2 Hereditary Angioedema Treatment Revenue by Manufacturers 3.2.1 Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020) 3.2.2 Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Hereditary Angioedema Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Treatment Revenue in 2019 3.2.5 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Hereditary Angioedema Treatment Price by Manufacturers 3.4 Hereditary Angioedema Treatment Manufacturing Base Distribution, Product Types 3.4.1 Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hereditary Angioedema Treatment Product Type 3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Hereditary Angioedema Treatment Market Size by Type (2015-2020) 4.1.1 Global Hereditary Angioedema Treatment Sales by Type (2015-2020) 4.1.2 Global Hereditary Angioedema Treatment Revenue by Type (2015-2020) 4.1.3 Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2021-2026) 4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2026) 4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2021-2026) 4.2.3 Hereditary Angioedema Treatment Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Hereditary Angioedema Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Hereditary Angioedema Treatment Market Size by Application (2015-2020) 5.1.1 Global Hereditary Angioedema Treatment Sales by Application (2015-2020) 5.1.2 Global Hereditary Angioedema Treatment Revenue by Application (2015-2020) 5.1.3 Hereditary Angioedema Treatment Price by Application (2015-2020) 5.2 Hereditary Angioedema Treatment Market Size Forecast by Application (2021-2026) 5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2026) 5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2021-2026) 5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2021-2026) 6 North America 6.1 North America Hereditary Angioedema Treatment by Country 6.1.1 North America Hereditary Angioedema Treatment Sales by Country 6.1.2 North America Hereditary Angioedema Treatment Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Hereditary Angioedema Treatment Market Facts & Figures by Type 6.3 North America Hereditary Angioedema Treatment Market Facts & Figures by Application 7 Europe 7.1 Europe Hereditary Angioedema Treatment by Country 7.1.1 Europe Hereditary Angioedema Treatment Sales by Country 7.1.2 Europe Hereditary Angioedema Treatment Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Hereditary Angioedema Treatment Market Facts & Figures by Type 7.3 Europe Hereditary Angioedema Treatment Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Hereditary Angioedema Treatment by Region 8.1.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region 8.1.2 Asia Pacific Hereditary Angioedema Treatment Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Type 8.3 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Application 9 Latin America 9.1 Latin America Hereditary Angioedema Treatment by Country 9.1.1 Latin America Hereditary Angioedema Treatment Sales by Country 9.1.2 Latin America Hereditary Angioedema Treatment Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Type 9.3 Central & South America Hereditary Angioedema Treatment Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Hereditary Angioedema Treatment by Country 10.1.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Country 10.1.2 Middle East and Africa Hereditary Angioedema Treatment Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Type 10.3 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Application 11 Company Profiles 11.1 CSL 11.1.1 CSL Corporation Information 11.1.2 CSL Description, Business Overview and Total Revenue 11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020) 11.1.4 CSL Hereditary Angioedema Treatment Products Offered 11.1.5 CSL Recent Development 11.2 Pharming Group 11.2.1 Pharming Group Corporation Information 11.2.2 Pharming Group Description, Business Overview and Total Revenue 11.2.3 Pharming Group Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered 11.2.5 Pharming Group Recent Development 11.3 Shire plc (Takeda Pharmaceutical Company Limited) 11.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information 11.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description, Business Overview and Total Revenue 11.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered 11.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development 11.4 Ionis Pharmaceuticals 11.4.1 Ionis Pharmaceuticals Corporation Information 11.4.2 Ionis Pharmaceuticals Description, Business Overview and Total Revenue 11.4.3 Ionis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered 11.4.5 Ionis Pharmaceuticals Recent Development 11.5 Attune Pharmaceuticals 11.5.1 Attune Pharmaceuticals Corporation Information 11.5.2 Attune Pharmaceuticals Description, Business Overview and Total Revenue 11.5.3 Attune Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered 11.5.5 Attune Pharmaceuticals Recent Development 11.6 BioCryst Pharmaceuticals 11.6.1 BioCryst Pharmaceuticals Corporation Information 11.6.2 BioCryst Pharmaceuticals Description, Business Overview and Total Revenue 11.6.3 BioCryst Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered 11.6.5 BioCryst Pharmaceuticals Recent Development 11.7 KalVista Pharmaceuticals 11.7.1 KalVista Pharmaceuticals Corporation Information 11.7.2 KalVista Pharmaceuticals Description, Business Overview and Total Revenue 11.7.3 KalVista Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered 11.7.5 KalVista Pharmaceuticals Recent Development 11.1 CSL 11.1.1 CSL Corporation Information 11.1.2 CSL Description, Business Overview and Total Revenue 11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020) 11.1.4 CSL Hereditary Angioedema Treatment Products Offered 11.1.5 CSL Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Hereditary Angioedema Treatment Market Estimates and Projections by Region 12.1.1 Global Hereditary Angioedema Treatment Sales Forecast by Regions 2021-2026 12.1.2 Global Hereditary Angioedema Treatment Revenue Forecast by Regions 2021-2026 12.2 North America Hereditary Angioedema Treatment Market Size Forecast (2021-2026) 12.2.1 North America: Hereditary Angioedema Treatment Sales Forecast (2021-2026) 12.2.2 North America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026) 12.2.3 North America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026) 12.3 Europe Hereditary Angioedema Treatment Market Size Forecast (2021-2026) 12.3.1 Europe: Hereditary Angioedema Treatment Sales Forecast (2021-2026) 12.3.2 Europe: Hereditary Angioedema Treatment Revenue Forecast (2021-2026) 12.3.3 Europe: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Hereditary Angioedema Treatment Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Hereditary Angioedema Treatment Market Size Forecast by Region (2021-2026) 12.5 Latin America Hereditary Angioedema Treatment Market Size Forecast (2021-2026) 12.5.1 Latin America: Hereditary Angioedema Treatment Sales Forecast (2021-2026) 12.5.2 Latin America: Hereditary Angioedema Treatment Revenue Forecast (2021-2026) 12.5.3 Latin America: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Hereditary Angioedema Treatment Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Hereditary Angioedema Treatment Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hereditary Angioedema Treatment Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

Get Free Sample

List of Tables Table 1. Hereditary Angioedema Treatment Market Segments Table 2. Ranking of Global Top Hereditary Angioedema Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Hereditary Angioedema Treatment Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Table 5. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonists (Firazyr) Table 6. Major Manufacturers of Kallikrein Inhibitors (Kalbitor, Takhzyro) Table 7. Major Manufacturers of Others (Conventional Drugs, Pipeline Drugs) Table 8. COVID-19 Impact Global Market: (Four Hereditary Angioedema Treatment Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Hereditary Angioedema Treatment Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact Table 13. Global Hereditary Angioedema Treatment Market Size Growth Rate by Application 2020-2026 (K Units) Table 14. Global Hereditary Angioedema Treatment Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 15. Global Hereditary Angioedema Treatment Sales by Regions 2015-2020 (K Units) Table 16. Global Hereditary Angioedema Treatment Sales Market Share by Regions (2015-2020) Table 17. Global Hereditary Angioedema Treatment Revenue by Regions 2015-2020 (US$ Million) Table 18. Global Hereditary Angioedema Treatment Sales by Manufacturers (2015-2020) (K Units) Table 19. Global Hereditary Angioedema Treatment Sales Share by Manufacturers (2015-2020) Table 20. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 21. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Treatment as of 2019) Table 22. Hereditary Angioedema Treatment Revenue by Manufacturers (2015-2020) (US$ Million) Table 23. Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020) Table 24. Key Manufacturers Hereditary Angioedema Treatment Price (2015-2020) (USD/Unit) Table 25. Hereditary Angioedema Treatment Manufacturers Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Hereditary Angioedema Treatment Product Type Table 27. Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans Table 29. Global Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units) Table 30. Global Hereditary Angioedema Treatment Sales Share by Type (2015-2020) Table 31. Global Hereditary Angioedema Treatment Revenue by Type (2015-2020) (US$ Million) Table 32. Global Hereditary Angioedema Treatment Revenue Share by Type (2015-2020) Table 33. Hereditary Angioedema Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 34. Global Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units) Table 35. Global Hereditary Angioedema Treatment Sales Share by Application (2015-2020) Table 36. North America Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units) Table 37. North America Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020) Table 38. North America Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million) Table 39. North America Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020) Table 40. North America Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units) Table 41. North America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020) Table 42. North America Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units) Table 43. North America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020) Table 44. Europe Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units) Table 45. Europe Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020) Table 46. Europe Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million) Table 47. Europe Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020) Table 48. Europe Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units) Table 49. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020) Table 50. Europe Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units) Table 51. Europe Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020) Table 52. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2015-2020) (K Units) Table 53. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020) Table 54. Asia Pacific Hereditary Angioedema Treatment Revenue by Region (2015-2020) (US$ Million) Table 55. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020) Table 56. Asia Pacific Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units) Table 57. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020) Table 58. Asia Pacific Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units) Table 59. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020) Table 60. Latin America Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units) Table 61. Latin America Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020) Table 62. Latin Americaa Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million) Table 63. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020) Table 64. Latin America Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units) Table 65. Latin America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020) Table 66. Latin America Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units) Table 67. Latin America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020) Table 68. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2015-2020) (K Units) Table 69. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country (2015-2020) Table 70. Middle East and Africa Hereditary Angioedema Treatment Revenue by Country (2015-2020) (US$ Million) Table 71. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country (2015-2020) Table 72. Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units) Table 73. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020) Table 74. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units) Table 75. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020) Table 76. CSL Corporation Information Table 77. CSL Description and Major Businesses Table 78. CSL Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 79. CSL Product Table 80. CSL Recent Development Table 81. Pharming Group Corporation Information Table 82. Pharming Group Description and Major Businesses Table 83. Pharming Group Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 84. Pharming Group Product Table 85. Pharming Group Recent Development Table 86. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information Table 87. Shire plc (Takeda Pharmaceutical Company Limited) Description and Major Businesses Table 88. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 89. Shire plc (Takeda Pharmaceutical Company Limited) Product Table 90. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development Table 91. Ionis Pharmaceuticals Corporation Information Table 92. Ionis Pharmaceuticals Description and Major Businesses Table 93. Ionis Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 94. Ionis Pharmaceuticals Product Table 95. Ionis Pharmaceuticals Recent Development Table 96. Attune Pharmaceuticals Corporation Information Table 97. Attune Pharmaceuticals Description and Major Businesses Table 98. Attune Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 99. Attune Pharmaceuticals Product Table 100. Attune Pharmaceuticals Recent Development Table 101. BioCryst Pharmaceuticals Corporation Information Table 102. BioCryst Pharmaceuticals Description and Major Businesses Table 103. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 104. BioCryst Pharmaceuticals Product Table 105. BioCryst Pharmaceuticals Recent Development Table 106. KalVista Pharmaceuticals Corporation Information Table 107. KalVista Pharmaceuticals Description and Major Businesses Table 108. KalVista Pharmaceuticals Hereditary Angioedema Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 109. KalVista Pharmaceuticals Product Table 110. KalVista Pharmaceuticals Recent Development Table 111. Global Hereditary Angioedema Treatment Sales Forecast by Regions (2021-2026) (K Units) Table 112. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Regions (2021-2026) Table 113. Global Hereditary Angioedema Treatment Revenue Forecast by Regions (2021-2026) (US$ Million) Table 114. Global Hereditary Angioedema Treatment Revenue Market Share Forecast by Regions (2021-2026) Table 115. North America: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units) Table 116. North America: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million) Table 117. Europe: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units) Table 118. Europe: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million) Table 119. Asia Pacific: Hereditary Angioedema Treatment Sales Forecast by Region (2021-2026) (K Units) Table 120. Asia Pacific: Hereditary Angioedema Treatment Revenue Forecast by Region (2021-2026) (US$ Million) Table 121. Latin America: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units) Table 122. Latin America: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million) Table 123. Middle East and Africa: Hereditary Angioedema Treatment Sales Forecast by Country (2021-2026) (K Units) Table 124. Middle East and Africa: Hereditary Angioedema Treatment Revenue Forecast by Country (2021-2026) (US$ Million) Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 126. Key Challenges Table 127. Market Risks Table 128. Main Points Interviewed from Key Hereditary Angioedema Treatment Players Table 129. Hereditary Angioedema Treatment Customers List Table 130. Hereditary Angioedema Treatment Distributors List Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Hereditary Angioedema Treatment Product Picture Figure 2. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2020 & 2026 Figure 3. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Product Picture Figure 4. Selective Bradykinin B2 Receptor Antagonists (Firazyr) Product Picture Figure 5. Kallikrein Inhibitors (Kalbitor, Takhzyro) Product Picture Figure 6. Others (Conventional Drugs, Pipeline Drugs) Product Picture Figure 7. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2020 & 2026 Figure 8. Hospital Pharmacies Figure 9. Retail Pharmacies Figure 10. Others (online pharmacies, mail pharmacies) Figure 11. Hereditary Angioedema Treatment Report Years Considered Figure 12. Global Hereditary Angioedema Treatment Market Size 2015-2026 (US$ Million) Figure 13. Global Hereditary Angioedema Treatment Sales 2015-2026 (K Units) Figure 14. Global Hereditary Angioedema Treatment Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020) Figure 16. Global Hereditary Angioedema Treatment Sales Market Share by Region in 2019 Figure 17. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020) Figure 18. Global Hereditary Angioedema Treatment Revenue Market Share by Region in 2019 Figure 19. Global Hereditary Angioedema Treatment Sales Share by Manufacturer in 2019 Figure 20. The Top 10 and 5 Players Market Share by Hereditary Angioedema Treatment Revenue in 2019 Figure 21. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020) Figure 23. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2019 Figure 24. Global Hereditary Angioedema Treatment Revenue Market Share by Type (2015-2020) Figure 25. Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2019 Figure 26. Global Hereditary Angioedema Treatment Market Share by Price Range (2015-2020) Figure 27. Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020) Figure 28. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2019 Figure 29. Global Hereditary Angioedema Treatment Revenue Market Share by Application (2015-2020) Figure 30. Global Hereditary Angioedema Treatment Revenue Market Share by Application in 2019 Figure 31. North America Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units) Figure 32. North America Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million) Figure 33. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2019 Figure 34. North America Hereditary Angioedema Treatment Revenue Market Share by Country in 2019 Figure 35. U.S. Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 36. U.S. Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Canada Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 38. Canada Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. North America Hereditary Angioedema Treatment Market Share by Type in 2019 Figure 40. North America Hereditary Angioedema Treatment Market Share by Application in 2019 Figure 41. Europe Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units) Figure 42. Europe Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million) Figure 43. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2019 Figure 44. Europe Hereditary Angioedema Treatment Revenue Market Share by Country in 2019 Figure 45. Germany Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 46. Germany Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. France Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 48. France Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. U.K. Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 50. U.K. Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Italy Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 52. Italy Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Russia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 54. Russia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Europe Hereditary Angioedema Treatment Market Share by Type in 2019 Figure 56. Europe Hereditary Angioedema Treatment Market Share by Application in 2019 Figure 57. Asia Pacific Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units) Figure 58. Asia Pacific Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million) Figure 59. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2019 Figure 60. Asia Pacific Hereditary Angioedema Treatment Revenue Market Share by Region in 2019 Figure 61. China Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 62. China Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Japan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 64. Japan Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. South Korea Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 66. South Korea Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. India Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 68. India Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Australia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 70. Australia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Taiwan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 72. Taiwan Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Indonesia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 74. Indonesia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Thailand Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 76. Thailand Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Malaysia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 78. Malaysia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Philippines Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 80. Philippines Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Vietnam Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 82. Vietnam Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Asia Pacific Hereditary Angioedema Treatment Market Share by Type in 2019 Figure 84. Asia Pacific Hereditary Angioedema Treatment Market Share by Application in 2019 Figure 85. Latin America Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Hereditary Angioedema Treatment Sales Market Share by Country in 2019 Figure 88. Latin America Hereditary Angioedema Treatment Revenue Market Share by Country in 2019 Figure 89. Mexico Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Latin America Hereditary Angioedema Treatment Market Share by Type in 2019 Figure 96. Latin America Hereditary Angioedema Treatment Market Share by Application in 2019 Figure 97. Middle East and Africa Hereditary Angioedema Treatment Sales Growth Rate 2015-2020 (K Units) Figure 98. Middle East and Africa Hereditary Angioedema Treatment Revenue Growth Rate 2015-2020 (US$ Million) Figure 99. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Country in 2019 Figure 100. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Country in 2019 Figure 101. Turkey Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 102. Turkey Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. Saudi Arabia Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 104. Saudi Arabia Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. U.A.E Hereditary Angioedema Treatment Sales Growth Rate (2015-2020) (K Units) Figure 106. U.A.E Hereditary Angioedema Treatment Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. Middle East and Africa Hereditary Angioedema Treatment Market Share by Type in 2019 Figure 108. Middle East and Africa Hereditary Angioedema Treatment Market Share by Application in 2019 Figure 109. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Pharming Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Shire plc (Takeda Pharmaceutical Company Limited) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 112. Ionis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 113. Attune Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 114. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 115. KalVista Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 116. North America Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. North America Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Europe Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units) Figure 119. Europe Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 120. Asia Pacific Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units) Figure 121. Asia Pacific Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 122. Latin America Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units) Figure 123. Latin America Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 124. Middle East and Africa Hereditary Angioedema Treatment Sales Growth Rate Forecast (2021-2026) (K Units) Figure 125. Middle East and Africa Hereditary Angioedema Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 126. Porter's Five Forces Analysis Figure 127. Channels of Distribution Figure 128. Distributors Profiles Figure 129. Bottom-up and Top-down Approaches for This Report Figure 130. Data Triangulation Figure 131. Key Executives Interviewed

Get Free Sample

Related Reports

COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

COVID-19 Impact on Global Hereditary Angioedema Treatment Market Insights, Forecast to 2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)